» Articles » PMID: 32808450

CircPSMC3 Alleviates the Symptoms of PCOS by Sponging MiR-296-3p and Regulating PTEN Expression

Overview
Journal J Cell Mol Med
Date 2020 Aug 19
PMID 32808450
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic ovary syndrome (PCOS), the most common female endocrine disease that causes anovulatory infertility, still lacks promising strategy for the accurate diagnosis and effective therapeutics of PCOS attributed to its unclear aetiology. In this study, we determined the abnormal reduction in circPSMC3 expression by comparing the ovarian tissue samples of PCOS patients and normal individuals. The symptom relief caused by up-regulation of circPSMC3 in PCOS model mice suggested the potential for further study. In vitro functional experiments confirmed that circPSMC3 can inhibit cell proliferation and promote apoptosis by blocking the cell cycle in human-like granular tumour cell lines. Mechanism study revealed that circPSMC3 may play its role through sponging miR-296-3p to regulate PTEN expression. Collectively, we preliminarily characterized the role and possible insights of circPSMC3/miR-296-3p/PTEN axis in the proliferation and apoptosis of KGN cells. We hope that this work provides some original and valuable information for the research of circRNAs in PCOS, not only to better understand the pathogenesis but also to help provide new clues for seeking for the future therapeutic target of PCOS.

Citing Articles

Circular RNAs as a novel class of potential therapeutic and diagnostic biomarkers in reproductive biology/diseases.

Song W, Chen X, Wu H, Rahimian N Eur J Med Res. 2024; 29(1):643.

PMID: 39741306 PMC: 11689626. DOI: 10.1186/s40001-024-02230-7.


Role of circular RNA/miRNA axes in the pathophysiology of polycystic ovary syndrome.

Ahmadi M, Fathi M, Malmir A, Ghafouri-Fard S Mol Biol Rep. 2024; 51(1):437.

PMID: 38520572 DOI: 10.1007/s11033-024-09376-x.


The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review.

Nasser J, Altahoo N, Almosawi S, Alhermi A, Butler A Int J Mol Sci. 2024; 25(2).

PMID: 38255975 PMC: 10815174. DOI: 10.3390/ijms25020903.


Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome.

Jing T, Wu Y, Wan A, Ge C, Chen Z, Du Y Biomolecules. 2023; 13(7).

PMID: 37509138 PMC: 10377156. DOI: 10.3390/biom13071101.


The complex metabolic interactions of liver tissue and hepatic exosome in PCOS mice at young and middle age.

Gao S, Long F, Jiang Z, Shi J, Ma D, Yang Y Front Physiol. 2022; 13:990987.

PMID: 36203935 PMC: 9531160. DOI: 10.3389/fphys.2022.990987.


References
1.
McCartney C, Marshall J . CLINICAL PRACTICE. Polycystic Ovary Syndrome. N Engl J Med. 2016; 375(1):54-64. PMC: 5301909. DOI: 10.1056/NEJMcp1514916. View

2.
Wilusz J, Sharp P . Molecular biology. A circuitous route to noncoding RNA. Science. 2013; 340(6131):440-1. PMC: 4063205. DOI: 10.1126/science.1238522. View

3.
Liu Y, Hou J, Zhang M, Seleh-Zo E, Wang J, Cao B . circ-016910 sponges miR-574-5p to regulate cell physiology and milk synthesis via MAPK and PI3K/AKT-mTOR pathways in GMECs. J Cell Physiol. 2019; 235(5):4198-4216. PMC: 7028128. DOI: 10.1002/jcp.29370. View

4.
Wei Y, Lu S, Hu Y, Guo L, Wu X, Liu X . MicroRNA-135a Regulates VEGFC Expression and Promotes Luteinized Granulosa Cell Apoptosis in Polycystic Ovary Syndrome. Reprod Sci. 2020; 27(7):1436-1442. DOI: 10.1007/s43032-020-00155-0. View

5.
Bai Y, Liao H, Liu T, Zeng X, Xiao F, Luo L . MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1). Eur J Cancer. 2012; 49(3):710-24. DOI: 10.1016/j.ejca.2012.08.020. View